Kinnevik News | Sep 27, 2024
Mews, a portfolio company of Kinnevik, has has secured another $100M in financing from Vista Credit Partners...
Brought to you by RivalSense - an AI tool for monitoring any company.
RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡
Kinnevik
🌎 kinnevik.comKinnevik is a venture capital investment firm based in Stockholm, Sweden, founded in 1936. The company focuses on being a leading growth investor in Europe, particularly in digital consumer businesses across sectors such as healthcare, software, marketplaces, and climate tech. Kinnevik aims to support challenger companies at various stages of their development, leveraging its nearly 100-year legacy of investing expertise to deliver significant returns while promoting sustainable business models and diverse teams.
Updates as of Sep 27, 2024
- Mews, a portfolio company of Kinnevik, has has secured another $100M in financing from Vista Credit Partners.
- Kinnevik has invested in Job&Talent, which operates in 10 countries and has raised approximately 850 million USD.
- Kinnevik AB Series A shares gained 6.5% on Tuesday.
- Kinnevik's total number of shares has been updated to 283,848,920 as of 2024-09-27.
- Kinnevik will host a capital markets day on 19 September, 2024.
- Kinnevik is a world-class investor backing TravelPerk, which partners with SilverRail to enable Amtrak rail for its customers.
- Christopher Perry has joined Kinnevik as Legal Counsel (Secondee) in England, previously serving as Director of Legal (Secondee) at MMC Ventures.
- Kinnevik grew its stake in Recursion Pharmaceuticals by 14.4% during the 2nd quarter, now owning 11,905,668 shares valued at $89,293,000.
Did you find it useful?
If you liked this report, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.